Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC: Chengdu Thursday, November 28, 2024, 10:00 Hrs [IST ...

Earlier this year, entrepreneur and women’s health advocate Sheila Mikhail received the Triangle Business Journal’s Lifetime ...

New movie The Substance showcases how women are thought about in terms of youth and fertility. That idea makes for bad research and health guidance.

The University of Kansas is working with biotechnology lab Design-Zyme to produce vaccines for both Lyme disease and Chlamydia.

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV businessPoint-of-Care product revenue ...

A cancer treatment similar to sac-TMT approved for marketing in China is Trodelvy (sacituzumab govitecan-hziy), developed by ...

North Wales Police said he was in a remote location above Maenan in the Conwy valley in Conwy county. America's Federal ...

announced it has hired Karen… Join us as we celebrate outstanding women at our 8th annual Women Who Mean Business… Build your skills: apply key compliance concepts to real-world scenarios at ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Daiichi Sankyo (TSE:4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have been awarded The Galien Foundation 2024 Prix Galien USA Award for Best Biotechnology Product for ENHERTU ® (fam-trastuzumab ...